Vera Therapeutics, Inc.
Status: Publicly traded
Direct answer
Vera Therapeutics, Inc. is publicly traded on NASDAQ under the ticker VERA.
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A...
Can you invest in Vera Therapeutics, Inc.?
Yes. Vera Therapeutics, Inc. is publicly traded on NASDAQ under the ticker VERA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Vera Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.